학술논문

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
Document Type
Article
Source
In ESMO Open October 2022 7(5)
Subject
Language
ISSN
2059-7029